Aridis Pharmaceuticals (ARDS)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Sep 5, 2024 02:38 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 32% (81 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 0.00 | 1.37 | 9.99 |
Current Quarter Estimate | NA | -10.52 | 61.00 |
Year Ago Quarter Estimate | 0.33 | -3.41 | 54.84 |
Next Quarter Estimate | NA | 3.10 | 63.00 |
Next Year Estimate | NA | 24.86 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | 17.20 | 15.70 |
Next Year | NA | 9.30 | 11.30 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 22.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.44 |
Price/Book (MRQ) | NA | 2.10 |
Price/Cash Flow (MRFY) | NA | 16.43 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -150.51% |
Return on Equity (TTM) | NA | -61.16% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.